小细胞肺癌NCCN指南最新版.docx
- 文档编号:26608221
- 上传时间:2023-06-20
- 格式:DOCX
- 页数:27
- 大小:2MB
小细胞肺癌NCCN指南最新版.docx
《小细胞肺癌NCCN指南最新版.docx》由会员分享,可在线阅读,更多相关《小细胞肺癌NCCN指南最新版.docx(27页珍藏版)》请在冰豆网上搜索。
小细胞肺癌NCCN指南最新版
PrintedbyqingBuon8/16/20122:
02:
09AM.Forpersonaluseonly.Notapprovedfordistribution.Copyright©2012NationalComprehensiveCancerNetwork,Inc.,AllRightsReserved.NCCNGuidelinesVersion2.2013SmallCellLungCancer157.MaranzanoE,TrippaF,CasaleM,etal.8Gysingle-doseradiotherapyiseffectiveinmetastaticspinalcordcompression:
resultsofaphaseIIIrandomizedmulticentreItaliantrial.RadiotherOncol2009;93:
174-179.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/19520448.158.LutzS,BerkL,ChangE,etal.Palliativeradiotherapyforbonemetastases:
anASTROevidence-basedguideline.IntJRadiatOncolBiolPhys2011;79:
965-976.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/21277118.159.FerrellB,KoczywasM,GrannisF,HarringtonA.Palliativecareinlungcancer.SurgClinNorthAm2011;91:
403-417,ix.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/21419260.160.TsaoMN,LloydN,WongRK,etal.Wholebrainradiotherapyforthetreatmentofnewlydiagnosedmultiplebrainmetastases.CochraneDatabaseSystRev2012;4:
CD003869.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/22513917.161.SchneiderBJ,SaxenaA,DowneyRJ.Surgeryforearly-stagesmallcelllungcancer.JNatlComprCancNetw2011;9:
1132-1139.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/21975913.162.LadT,PiantadosiS,ThomasP,etal.Aprospectiverandomizedtrialtodeterminethebenefitofsurgicalresectionofresidualdiseasefollowingresponseofsmallcelllungcancertocombinationchemotherapy.Chest1994;106:
320S-323S.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/7988254.163.RostadH,NaalsundA,JacobsenR,etal.SmallcelllungcancerinNorway.Shouldmorepatientshavebeenofferedsurgicaltherapy?
EurJCardiothoracSurg2004;26:
782-786.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/15450573.164.InoueM,MiyoshiS,YasumitsuT,etal.SurgicalresultsforsmallcelllungcancerbasedonthenewTNMstagingsystem.ThoracicSurgeryStudyGroupofOsakaUniversity,Osaka,Japan.AnnThoracSurg2000;70:
1615-1619.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/11093496.NCCNGuidelinesIndexSCLCTableofContentsDiscussion165.BrockMV,HookerCM,SyphardJE,etal.Surgicalresectionoflimiteddiseasesmallcelllungcancerintheneweraofplatinumchemotherapy:
Itstimehascome.JThoracCardiovascSurg2005;129:
64-72.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/15632826.166.LimE,BelcherE,YapYK,etal.Theroleofsurgeryinthetreatmentoflimiteddiseasesmallcelllungcancer:
timetoreevaluate.JThoracOncol2008;3:
1267-1271.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/18978561.167.ShieldsTW,HigginsGA,Jr.,MatthewsMJ,KeehnRJ.Surgicalresectioninthemanagementofsmallcellcarcinomaofthelung.JThoracCardiovascSurg1982;84:
481-488.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/6289013.168.SchreiberD,RineerJ,WeedonJ,etal.Survivaloutcomeswiththeuseofsurgeryinlimited-stagesmallcelllungcancer:
shoulditsrolebere-evaluated?
Cancer2010;116:
1350-1357.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/20082453.169.InoueM,NakagawaK,FujiwaraK,etal.Resultsofpreoperativemediastinoscopyforsmallcelllungcancer.AnnThoracSurg2000;70:
1620-1623.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/11093497.170.ShepherdFA,EvansWK,FeldR,etal.Adjuvantchemotherapyfollowingsurgicalresectionforsmall-cellcarcinomaofthelung.JClinOncol1988;6:
832-838.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/2835443.171.TsuchiyaR,SuzukiK,IchinoseY,etal.PhaseIItrialofpostoperativeadjuvantcisplatinandetoposideinpatientswithcompletelyresectedstageI-IIIasmallcelllungcancer:
theJapanClinicalOncologyLungCancerStudyGroupTrial(JCOG9101.JREF-12Version2.2013,07/06/12©NationalComprehensiveCancerNetwork,Inc.2012,Allrightsreserved.TheNCCNGuidelines®andthisillustrationmaynotbereproducedinanyformwithouttheexpresswrittenpermissionofNCCN®.
PrintedbyqingBuon8/16/20122:
02:
09AM.Forpersonaluseonly.Notapprovedfordistribution.Copyright©2012NationalComprehensiveCancerNetwork,Inc.,AllRightsReserved.NCCNGuidelinesVersion2.2013SmallCellLungCancerThoracCardiovascSurg2005;129:
977-983.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/15867769.172.JohnsonBE,LinnoilaRI,WilliamsJP,etal.Riskofsecondaerodigestivecancersincreasesinpatientswhosurvivefreeofsmallcelllungcancerformorethan2years.JClinOncol1995;13:
101-111.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/7799009.173.JohnsonBE.Secondlungcancersinpatientsaftertreatmentforaninitiallungcancer.JNatlCancerInst1998;90:
1335-1345.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/9747865.174.RichardsonGE,TuckerMA,VenzonDJ,etal.Smokingcessationaftersuccessfultreatmentofsmall-celllungcancerisassociatedwithfewersmoking-relatedsecondprimarycancers.AnnInternMed1993;119:
383-390.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/8393311.175.KawaharaM,UshijimaS,KamimoriT,etal.Secondprimarytumoursinmorethan2-yeardisease-freesurvivorsofsmall-celllungcancerinJapan:
theroleofsmokingcessation.BrJCancer1998;78:
409-412.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/9703291.176.ParsonsA,DaleyA,BeghR,AveyardP.Influenceofsmokingcessationafterdiagnosisofearlystagelungcanceronprognosis:
systematicreviewofobservationalstudieswithmeta-analysis.BMJ2010;340:
b5569.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/20093278.177.TravisW,BrambillaE,Müller-HermelinkH.WorldHealthOrganizationClassificationoftumours:
Pathologyandgeneticsoftumoursofthelung,pleura,thymusandheart.Lyon,France:
IARCPress;2004.178.BajettaE,CatenaL,ProcopioG,etal.IsthenewWHOclassificationofneuroendocrinetumoursusefulforselectinganNCCNGuidelinesIndexSCLCTableofContentsDiscussionappropriatetreatment?
AnnOncol2005;16:
1374-1380.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/15939719.179.KalemkerianGP.Pulmonaryneuroendocrinecarcinomas:
progressandpitfalls.JNatlComprCancNetw2011;9:
1081-1082.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/21975910.180.VarlottoJM,Medford-DavisLN,RechtA,etal.Shouldlargecellneuroendocrinelungcarcinomabeclassifiedandtreatedasasmallcelllungcancerorwithotherlargecellcarcinomas?
JThoracOncol2011;6:
1050-1058.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/21566535.181.TravisWD,GirouxDJ,ChanskyK,etal.TheIASLCLungCancerStagingProject:
proposalsfortheinclusionofbroncho-pulmonarycarcinoidtumorsintheforthcoming(seventheditionoftheTNMClassificationforLungCancer.JThoracOncol2008;3:
1213-1223.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/18978555.182.PuscedduS,CatenaL,ValenteM,etal.Long-termfollowupofpatientsaffectedbypulmonarycarcinoidattheIstitutoNazionaleTumoriofMilan:
aretrospectiveanalysis.JThoracDis2010;2:
16-20.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/22263011.183.KyrissT,MaierS,VeitS,etal.Carcinoidlungtumors:
long-termresultsfrom111resections.ThoracSurgSci2006;3:
Doc03.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/21289951.184.ReaF,RizzardiG,ZuinA,etal.Outcomeandsurgicalstrategyinbronchialcarcinoidtumors:
singleinstitutionexperiencewith252patients.EurJCardiothoracSurg2007;31:
186-191.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/17140801.185.DetterbeckFC.Managementofcarcinoidtumors.AnnThoracSurg2010;89:
998-1005.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/20172187.Version2.2013,07/06/12©NationalComprehensiveCancerNetwork,Inc.2012,Allrightsreserved.TheNCCNGuidelines®andthisillustrationmaynotbereproducedinanyformwithouttheexpresswrittenpermissionofNCCN®.REF-13
PrintedbyqingBuon8/16/20122:
02:
09AM.Forpersonaluseonly.Notapprovedfordistribution.Copyright©2012NationalComprehensiveCancerNetwork,Inc.,AllRightsReserved.NCCNGuidelinesVersion2.2013SmallCellLungCancer186.CardilloG,SeraF,DiMartinoM,etal.Bronchialcarcinoidtumors:
nodalstatusandlong-termsurvivalafterresection.AnnThoracSurg2004;77:
1781-1785.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/15111186.187.WirthLJ,CarterMR,JannePA,JohnsonBE.Outcomeofpatientswithpulmonarycarcinoidtumorsreceivingchemotherapyorchemoradiotherapy.LungCancer2004;44:
213-220.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/15084386.188.YaoJC,PhanAT,ChangDZ,etal.EfficacyofRAD001(everolimusandoctreotideLARinadvancedlow-tointermediategradeneuroendocrinetumors:
resultsofaphaseIIstudy.JClinOncol2008;26:
4311-4318.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/18779618.189.MoertelCG,KvolsLK,O'ConnellMJ,RubinJ.Treatmentofneuroendocrinecarcinomaswithcombinedetoposideandcisplatin.Evidenceofmajortherapeuticactivityintheanaplasticvariantsoftheseneoplasms.Cancer1991;68:
227-232.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/1712661.190.EkebladS,SundinA,JansonET,etal.Temozolomideasmonotherapyiseffectiveintreatmentofadvancedmalignantneuroendocrinetumors.ClinCancerRes2007;13:
2986-2991.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/17505000.191.KulkeMH,HornickJL,FrauenhofferC,etal.O6-methylguanineDNAmethyltransferasedeficiencyandresponsetotemozolomidebasedtherapyinpatientswithneuroendocrinetumors.ClinCancerRes2009;15:
338-345.Availableat:
http:
//www.ncbi.nlm.nih.gov/pubmed/19118063.192.KulkeMH,LenzHJ,MeropolNJ,etal.Activityof
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 细胞 肺癌 NCCN 指南 最新版
![提示](https://static.bdocx.com/images/bang_tan.gif)